Cannabis Bioscience International Holdings, Inc. (CBIH) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Cannabis Bioscience International Holdings, Inc. (CBIH) stock forecast summary
Our AI scores Cannabis Bioscience International Holdings, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Its market capitalization is not available, so no size classification is given. Its Current Ratio of 0.00x is the lowest of the 16 peers that report one.
For CBIH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 20.0%, measured on 305 forecast dates between 2023-08-18 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 7.0%, measured on 348 forecast dates between 2023-08-18 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CBIH included.
CBIH price chart and AI forecast
How CBIH ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cannabis Bioscience International Holdings, Inc. (CBIH) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Commercial Physical & Biological Research peers listed below that report each metric.
Valuation & Market
| Metric | CBIH | Rank |
|---|---|---|
| EPS | $0.00 | – |
Profitability & Margins
| Metric | CBIH | Rank |
|---|---|---|
| ROA | -31398.1% | 10/10 |
| ROIC | 32.3% | 3/11 |
| Gross Margin | 60.3% | 3/7 |
| Operating Margin | -379.5% | 10/13 |
| Net Margin | -467.9% | 8/9 |
| EBT Margin | -379.5% | 10/13 |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | CBIH | Rank |
|---|---|---|
| Current Ratio | 0.00x | 16/16 |
| Interest Coverage | -2.7x | 8/14 |
| Working Capital | -$1M | 9/15 |
Cash Flow
| Metric | CBIH | Rank |
|---|---|---|
| Operating Cash Flow | -$280K | 9/15 |
Income Statement
| Metric | CBIH | Rank |
|---|---|---|
| Operating Income | -$390K | 8/15 |
| Net Income | -$480K | 6/11 |
| Cost of Goods Sold | $40K | 8/8 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $0.00M | |
| Cash & Short-term Investments | $0.00M | |
| Accounts Receivable | $0.00M | |
| Total Liabilities | $1M |
CBIH quarterly financials and insider trading
Cannabis Bioscience International Holdings, Inc. (CBIH) industry peers
Companies classified under the same SEC industry code as Cannabis Bioscience International Holdings, Inc. (Services-Commercial Physical & Biological Research): 16 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CBIH Cannabis Bioscience International Holdings, Inc. | N/A | |
| IQV Iqvia Holdings Inc. | $44.80B | |
| INCY Incyte Corp | $24.39B | |
| MEDP Medpace Holdings, Inc. | $18.27B | |
| CRL Charles River Laboratories International, Inc. | $16.11B | |
| ICLR Icon Plc | $15.34B | |
| ABSI Absci Corp | $1.75B | |
| OABI Omniab, Inc. | $705M | |
| NRC Nrc Health | $572M | |
| MXCT Maxcyte, Inc. | $130M | |
| ONMD Onemednet Corp | $25M | |
| BIAF Bioaffinity Technologies, Inc. | $3M | |
| VSBC Vitaspring Biomedical Co. Ltd. | $3M | |
| BUDZ Weed, Inc. | $3M | |
| ISPC Ispecimen Inc. | $2M | |
| FOXO Foxo Technologies Inc. | $170K |
Where CBIH sits on the market map
Cannabis Bioscience International Holdings, Inc. (CBIH) stock news
Loading...
Cannabis Bioscience International Holdings, Inc. (CBIH) stock forecast FAQ
What is the Cannabis Bioscience International Holdings, Inc. (CBIH) stock forecast?
Our AI scores Cannabis Bioscience International Holdings, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Cannabis Bioscience International Holdings, Inc. stock predictions?
For CBIH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 20.0%, measured on 305 forecast dates between 2023-08-18 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 7.0%, measured on 348 forecast dates between 2023-08-18 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cannabis Bioscience International Holdings, Inc. forecasts updated?
Cannabis Bioscience International Holdings, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Cannabis Bioscience International Holdings, Inc.'s industry peers?
16 issuers in our coverage, CBIH included, share the SEC industry code Services-Commercial Physical & Biological Research. The largest are: Iqvia Holdings Inc. (IQV), Incyte Corp (INCY), Medpace Holdings, Inc. (MEDP), Charles River Laboratories International, Inc. (CRL), Icon Plc (ICLR), Absci Corp (ABSI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.